Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.37 | N/A |
| PEG Ratio (TTM) | 8.28 | N/A |
| P/S Ratio (TTM) | 2.23 | N/A |
| P/B Ratio (TTM) | 5.28 | N/A |
| P/FCF Ratio (TTM) | 23.89 | N/A |
| Price to 5YR AVG Earnings Ratio | 25.45 | N/A |
| Price to 5YR AVG FCF Ratio | 25.23 | N/A |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 13.83% | N/A |
| ROE (TTM) | 28.58% | N/A |
| Net Profit Margin (TTM) | 11.56% | N/A |
| ROIC 5YR AVG | 27.17% | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 2.64% | 9.31% | 10.77% |
| Revenue | 1.62% | 5.72% | 5.09% |
| Net Income | 2.27% | 7.94% | 9.40% |
| Cash Flow | -6.85% | -7.11% | 16.90% |
Health (82%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.85 | N/A |
| Quick Ratio (TTM) | 1.20 | N/A |
| D/E Ratio (TTM) | 0.42 | N/A |
| Interest Coverage (TTM) | 25.71 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 6.46 | N/A |
| LTL to 5YR AVG FCF | 1.63 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.21% | N/A |